[Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial]

C Chagnaud; G Moulin; L Delannoy; J Y Gaubert; D Haddad; J M Bartoli; M Kasbarian

[Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial]

Ann Radiol (Paris). 1992;35(4 Pt 2):276-9.

[Article in French]

Authors

C Chagnaud¹, G Moulin, L Delannoy, J Y Gaubert, D Haddad, J M Bartoli, M Kasbarian

Affiliation

¹ Service Central de Radiologie Adultes, Groupe Hospitalier de la Timone, Marseille.

PMID: 1296491

Abstract

The authors compared ioversol 300 to iopamidol 300 by double blind study in patients undergoing enhanced computed body tomography. There was no significant difference in clinical tolerance and efficacy between the two products. Only minor reactions were recorded in both groups. Contrast media were not considered to be responsible for the poor diagnostic quality of a few explorations. Ioversol 300 appears as a well tolerated and effective contrast medium for computed body tomography.

Publication types

Clinical Trial
Comparative Study
Controlled Clinical Trial

MeSH terms

Adult
Aortic Aneurysm, Abdominal / diagnostic imaging
Arteriosclerosis Obliterans / diagnostic imaging
Contrast Media
Double-Blind Method
Female
Humans
Iopamidol* / adverse effects
Kidney Diseases / diagnostic imaging
Male
Neoplasms / diagnostic imaging
Tomography, X-Ray Computed / methods*
Triiodobenzoic Acids* / adverse effects
Whole-Body Irradiation

Substances

Contrast Media
Triiodobenzoic Acids
Iopamidol
ioversol